DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
Open accessAbstract
Purpose: Contrary to the extensive data accumulated regarding pancreatic carcinogenesis, the clinical and molecular features characteristic of advanced stage (stage III and IV) disease are unknown. A comprehensive study of pancreatic cancers from patients who have succumbed to their disease has the potential to greatly expand our understanding of the most lethal stage of this disease and identify novel areas for intervention. Materials and Methods: Rapid autopsies were performed on 76 patients with documented pancreatic cancer. The histologic features of end stage disease were determined and correlated to the stage at initial diagnosis, patterns of failure (locally destructive v metastatic disease) and the status of the KRAS2, TP53, and DPC4 genes. Results: At autopsy, 30% of patients died with locally destructive pancreatic cancer, and 70% died with widespread metastatic disease. These divergent patterns of failure found at autopsy (locally destructive v metastatic) were unrelated to clinical stage at initial presentation, treatment history, or histopathologic features. However, Dpc4 immunolabeling status of carcinoma tissues harvested at autopsy, a sensitive marker of DPC4 genetic status, was highly correlated with the presence of widespread metastasis but not with locally destructive tumors (P = .007). Conclusion: Pancreatic cancers are represented by distinct genetic subtypes with significantly different patterns of failure. Determinations of DPC4 status at initial diagnosis may be of value in stratifying patients into treatment regimens related to local control versus systemic therapy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SMAD4 loss is associated with higher rates of metastatic dissemination during neoadjuvant therapy and terminal disease.
“is associated with higher rates of metastatic dissemination during neoadjuvant therapy and terminal disease55,56.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184 · see citing works
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439 · see citing works
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,245 · see citing works
Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848 · see citing works
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P. D., Burant, C., Zhang, L., Adsay, V. N., Wicha, M. S., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,344 · see citing works
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609 · see citing works
Self-citationA molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2002) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,448 · see citing works
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,491 · see citing works
Self-citationResected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators
Riall, T. S., Yeo, C. J., Cameron, J. L., Koniaris, L. G., Kaushal, S., Abrams, R. A., Sauter, P. K., Coleman, J., Hruban, R. H., & Lillemoe, K. D. (2000) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(00)80105-5 · Cited by 1,482 · see citing works
Self-citationProgression model for pancreatic cancer.
Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 872 · see citing works
Self-citationTumor-suppressive pathways in pancreatic carcinoma.
Rozenblum, E., Schutte, M. E. M., Goggins, M., Hahn, S. A., Panzer, S., ZAHURAK, M. L., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., et al. (1997) · PubMed · Cited by 693 · see citing works
Self-citationFeldmann, G., Dhara, S., Fendrich, V., Bedja, D., Beaty, R. M., Mullendore, M. E., Karikari, C. A., Alvarez, H., Iacobuzio–Donahue, C. A., Jimeno, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3281 · Cited by 685 · see citing works
Self-citationBardeesy, N., Cheng, K.-H., Berger, J. H., Chu, G. C., Pahler, J., Olson, P., Hezel, A. F., Horner, J., Lauwers, G. Y., Hanahan, D., et al. (2006) · Genes & Development · doi:10.1101/gad.1478706 · Cited by 674 · see citing works
National Failure to Operate on Early Stage Pancreatic Cancer
Bilimoria, K. Y., Bentrem, D. J., Ko, C. Y., Stewart, A. K., Winchester, D. P., & Talamonti, M. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3180691579 · Cited by 554 · see citing works
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
Kang, Y., He, W., Tulley, S., Gupta, G. P., Serganova, I. S., Chen, C.-R., Manova-Todorova, K. O., Blasberg, R. G., Gerald, W. L., & Massagué, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506517102 · Cited by 531 · see citing works
Redston, M. S., Caldas, C., Seymour, A. B., Hruban, R. H., da Costa, L., Yeo, C. J., & Kern, S. E. (1994) · PubMed · Cited by 451 · see citing works
Self-citationIacobuzio–Donahue, C. A., Ashfaq, R., Maitra, A., Adsay, V. N., Shen-Ong, G. L. C., Berg, K. D., Hollingsworth, M. A., Cameron, J. L., Yeo, C. J., Kern, S. E., et al. (2003) · PubMed · Cited by 415 · see citing works
Self-citationDifferentiation plasticity regulated by TGF-β family proteins in development and disease
Derynck, R., & Akhurst, R. J. (2007) · Nature Cell Biology · doi:10.1038/ncb434 · Cited by 383 · see citing works
Deckers, M., van Dinther, M., Buijs, J., Que, I., Löwik, C., van der Pluijm, G., & ten Dijke, P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3560 · Cited by 379 · see citing works
Laheru, D. A., Lutz, E. R., Burke, J., Biedrzycki, B. A., Solt, S., Onners, B., Tartakovsky, I., Nemunaitis, J. J., Le, D. T., Sugar, E. A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0371 · Cited by 346 · see citing works
Self-citationAllelotype of pancreatic adenocarcinoma using xenograft enrichment.
Hahn, S. A., Ab, S., Hoque, A. T., Schutte, M. E. M., da Costa, L. T., Redston, M. S., Caldas, C., Weinstein, C. L., Fischer, A., & Yeo, C. J. (1995) · PubMed · Cited by 310 · see citing works
Self-citation(2001) · PubMed · Cited by 309 · see citing works
Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic Adenocarcinomas
Wilentz, R. E., Su, G. H., Dai, J. L., Sparks, A. B., Argani, P., Sohn, T. A., Yeo, C. J., Kern, S. E., & Hruban, R. H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64703-7 · Cited by 304 · see citing works
Self-citationDifferentiation plasticity regulated by TGF-|[beta]| family proteins in development and disease
Derynck, R., & Akhurst, R. J. (2007) · Nature · doi:10.1038/ncb0907-1000 · Cited by 227 · see citing works
Surgical Therapy for Colorectal Metastases to the Liver
Pawlik, T. M., & Choti, M. A. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-006-0061-3 · Cited by 222 · see citing works
Molecular pathogenesis of pancreatic cancer
Maitra, A., Kern, S. E., & Hruban, R. H. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.10.002 · Cited by 199 · see citing works
Self-citation<i>DPC4</i>/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma
Biankin, A. V., Morey, A. L., Lee, C.-S., Kench, J. G., Biankin, S. A., Hook, H. C., Head, D. R., Hugh, T. B., Sutherland, R. L., & Henshall, S. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.063 · Cited by 163 · see citing works
TGFβ-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN
Vogelmann, R., Nguyen-tat, M.-D., Giehl, K., Adler, G., Wedlich, D., & Menke, A. (2005) · Journal of Cell Science · doi:10.1242/jcs.02594 · Cited by 159 · see citing works
Molecular pathogenesis of pancreatic cancer
Hansel, D. E., Kern, S. E., & Hruban, R. H. (2003) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.4.070802.110341 · Cited by 159 · see citing works
Self-citationAbsence of E-Cadherin Expression Distinguishes Noncohesive from Cohesive Pancreatic Cancer
Winter, J. M., Ting, A. H., Vilardell, F., Gallmeier, E., Baylin, S. B., Hruban, R. H., Kern, S. E., & Iacobuzio–Donahue, C. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0487 · Cited by 153 · see citing works
Self-citationEmbuscado, E. E., Laheru, D. A., Ricci, F., Yun, K. J., Witzel, S. D. B., Seigel, A., Flickinger, K., Hidalgo, M. M., Bova, G. S., & Iacobuzio–Donahue, C. A. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.5.1663 · Cited by 151 · see citing works
Self-citationHematogenous Metastases of Pancreatic Ductal Carcinoma
Kamisawa, T., Isawa, T., Koike, M., et al. (1995) · Pancreas · doi:10.1097/00006676-199511000-00005 · Cited by 139 · see citing works
Mao, C. (1995) · Archives of Surgery · doi:10.1001/archsurg.1995.01430020015001 · Cited by 103 · see citing works
Iacobuzio–Donahue, C. A., Song, J., Parmiagiani, G., Yeo, C. J., Hruban, R. H., & Kern, S. E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1121-3 · Cited by 93 · see citing works
Self-citationVerslype, C., Cutsem, E. V., Dicato, M. A., Cascinu, S., Cunningham, D., Díaz‐Rubio, E., Glimelius, B. L. G., Haller, D. G., Haustermans, K. M., Heinemann, V., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm210 · Cited by 65 · see citing works
Suemizu, H., Monnai, M., Ohnishi, Y., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.4.741 · Cited by 64 · see citing works
Tanaka, T., Watanabe, T., Kazama, Y., Tanaka, J., Kanazawa, T., Kazama, S., & Nagawa, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603460 · Cited by 50 · see citing works
Dynamics of metastasis suppressor gene inactivation
Michor, F., & Iwasa, Y. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.01.006 · Cited by 18 · see citing works
Nakahashi, C., Oda, T., Kinoshitá, T., et al. (2003) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:33:2-3:155 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348 · see citing works
Moffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G. H., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., et al. (2015) · Nature Genetics · doi:10.1038/ng.3398 · Cited by 2,194 · see citing works
Self-citationStromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085 · see citing works
Self-citationPancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321 · see citing works
Molecular subtypes of pancreatic cancer
Collisson, E. A., Bailey, P., Chang, D. K., & Biankin, A. V. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0109-y · Cited by 892 · see citing works
Groot, V. P., Rezaee, N., Wu, W., Cameron, J. L., Fishman, E. K., Hruban, R. H., Weiss, M. J., Zheng, L., Wolfgang, C. L., & He, J. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002234 · Cited by 757 · see citing works
Self-citation<i>SMAD4</i> Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
Blackford, A., Serrano, O. K., Wolfgang, C. L., Parmigiani, G., Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Eshleman, J. R., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0227 · Cited by 371 · see citing works
Self-citationPancreatic cancer evolution and heterogeneity: integrating omics and clinical data
Connor, A. A., & Gallinger, S. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00418-1 · Cited by 369 · see citing works
Golan, T., Khvalevsky, E. Z., Hubert, A., Gabai, R. M., Hen, N., Segal, A., Domb, A., Harari, G., David, E. B., Raskin, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4183 · Cited by 336 · see citing works
Yachida, S., White, C. M., Naito, Y., Zhong, Y., Brosnan, J. A., Macgregor-Das, A. M., Morgan, R. A., Saunders, T., Laheru, D. A., Herman, J. M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1215 · Cited by 280 · see citing works
Self-citationQian, Z. R., Rubinson, D. A., Nowak, J. A., Morales-Oyarvide, V., Dunne, R. F., Kozak, M. M., Welch, M. W., Brais, L. K., Da Silva, A., Li, T., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3420 · Cited by 260 · see citing works
Duijts, S. F. A., van Beurden, M., Oldenburg, H. S. A., Hunter, M. S., Kieffer, J. M., Stuiver, M. M., Gerritsma, M. A., Menke-Pluymers, M. B. E., Plaisier, P. W., Rijna, H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.8525 · Cited by 220 · see citing works
The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance
Ahmed, S., Bradshaw, A.-D., Gera, S., Dewan, M., & Xu, R. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6010005 · Cited by 174 · see citing works
Hu, H.-F., Ye, Z., Qin, Y., Xu, X.-W., Yu, X.-J., Zhuo, Q.-F., & Ji, S.-R. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00584-2 · Cited by 149 · see citing works
Why is pancreatic cancer so deadly? The pathologist's view
Hruban, R. H., Gaida, M. M., Thompson, E., Hong, S., Noë, M., Brosens, L. A., Jongepier, M., Offerhaus, G. J. A., & Wood, L. D. (2019) · The Journal of Pathology · doi:10.1002/path.5260 · Cited by 115 · see citing works
Self-citationZhou, P., Li, Y., Li, B., Zhang, M., Liu, Y., Yao, Y., & Li, D. (2019) · Oncogene · doi:10.1038/s41388-019-0806-6 · Cited by 108 · see citing works
Dal Molin, M., Zhang, M., de Wilde, R. F., Ottenhof, N. A., Rezaee, N., Wolfgang, C. L., Blackford, A., Vogelstein, B., Kinzler, K. W., Papadopoulos, N., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2600 · Cited by 101 · see citing works
Self-citationWang, C., Zhang, T., Liao, Q., Dai, M., Guo, J., Yang, X., Tan, W., Lin, D., Wu, C., & Zhao, Y. (2021) · Protein & Cell · doi:10.1007/s13238-020-00760-4 · Cited by 82 · see citing works
Prognostic Value of SMAD4 in Pancreatic Cancer: A Meta-Analysis
Shugang, X., Hongfa, Y., Jianpeng, L., Xu, Z., Jingqi, F., Xiangxiang, L., & Wei, L. (2016) · Translational Oncology · doi:10.1016/j.tranon.2015.11.007 · Cited by 72 · see citing works
SMAD4 Expression Predicts Local Spread and Treatment Failure in Resected Pancreatic Cancer
Yamada, S., Fujii, T., Shimoyama, Y., Kanda, M., Nakayama, G., Sugimoto, H., Koike, M., Nomoto, S., Fujiwara, M., Nakao, A., et al. (2015) · Pancreas · doi:10.1097/mpa.0000000000000315 · Cited by 71 · see citing works
Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern
Kim, H. W., Lee, J.-C., Paik, K.-H., Kang, J., Kim, J., & Hwang, J.-H. (2017) · Medicine · doi:10.1097/md.0000000000005926 · Cited by 52 · see citing works
Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases
Bechard, M. E., Word, A. E., Tran, A. V., Liu, X., Locasale, J. W., & McDonald, O. G. (2018) · Oncogene · doi:10.1038/s41388-018-0346-5 · Cited by 35 · see citing works
Bechard, M. E., Smalling, R., Hayashi, A., Zhong, Y., Word, A. E., Campbell, S. L., Tran, A. V., Weiss, V. L., Iacobuzio-Donahue, C., Wellen, K. E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17839-5 · Cited by 33 · see citing works
Self-citationEcker, B. L., Court, C. M., Janssen, Q. P., Tao, A. J., D’Angelica, M. I., Drebin, J. A., Gonen, M., O’Reilly, E. M., Jarnagin, W. R., Wei, A. C., et al. (2022) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000000212 · Cited by 13 · see citing works
Sinha, A., Cherba, D., Bartlam, H., Lenkiewicz, E., Evers, L., Barrett, M. T., & Haab, B. B. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.04.007 · Cited by 11 · see citing works
Prognostic value of SMAD4 in resectable pancreatic cancer
Su, H., & Wang, C. (2022) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2022-0036 · Cited by 1 · see citing works
- Authors
- Iacobuzio-Donahue, C. A., Fu, B., Yachida, S., Luo, M., Abe, H., Henderson, C. M., Vilardell, F., Wang, Z., Keller, J. W., Banerjee, P., Herman, J. M., Cameron, J. L., Yeo, C. J., Halushka, M. K., Eshleman, J. R., Raben, M., Klein, A. P., Hruban, R. H., Hidalgo, M., & Laheru, D.
- Affiliations
- From the Departments of Pathology, Surgery, and Oncology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore MD; and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and Department of Surgery and the Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia PA.
- Johns Hopkins University (US)
- ORCID
- Venue
- Journal of Clinical Oncology
- Published
- 2009-04-10
- Volume
- 27
- Issue
- 11
- Pages
- 1806-1813
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- PMC
- PMC2668706
- OpenAlex
- W2118797060
- Cited by
- 1,081
- References
- 39
- Citations by year
- 2026: 29 · 2025: 34 · 2024: 45 · 2023: 60 · 2022: 59 · 2021: 87 · 2020: 67 · 2019: 69 · 2018: 75 · 2017: 103 · 2016: 81 · 2015: 89 · 2014: 90 · 2013: 71 · 2012: 59
- FWCI
- 19.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Rolfe Pancreatic Cancer Foundation
- National Institutes of Health (CA62924)
- National Cancer Institute (K08CA106610, CA106610, P50CA062924, CA 62924)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
- Keywords
- pancreatic cancer, failure patterns, metastasis, KRAS2, TP53, autopsy, genetic subtypes, advanced disease
- MeSH terms
- Adenocarcinoma, Aged, Autopsy, Female, Humans, Male, Middle Aged, Pancreatic Neoplasms, Predictive Value of Tests, Prognosis, Proto-Oncogene Proteins, Survival Analysis, Genes, p53, Proto-Oncogene Proteins p21(ras), Treatment Failure, Carcinoma, Adenosquamous, ras Proteins, Smad4 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
